Print page content Print
Increase text size Decrease text size
Text Size


Clostridium Perfringens Types C and D Bacterin-Toxoid

For use in healthy cattle and sheep as an aid in preventing enterotoxemia and enteritis caused by Clostridium perfringens Types B, C and D.  Although Cl. perfringens Type B is not a significant problem in North America, immunity is provided by the beta toxoid Type C and the epsilon toxoid Type D. Ultrabac CD consists of killed, standardized cultures of Cl. perfringens Types C and D, with an adjuvant.

Collapse All
  • Uses

    Aids in the prevention of enterotoxemia and enteritis caused by Clostridium perfringens Types B, C and D.

    Key Features

    • Helps prevent clostridial diseases which continue to be of economic importance in cattle. Clostridium bacteria are universally present and produce potent toxins that can result in rapid death of otherwise healthy animals.
    • Helps prevent enterotoxemia and enteritis caused by CI. perfringens Types B, C and D.
    • Subcutaneous (SC) dose is 2 mL followed by a second dose given four to six weeks later.  Annual revaccination with a single dose is recommended.
  • Precautions

    Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.



We are Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.